These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 37477905)
1. Drug-drug interaction of Nirmatrelvir/ritonavir and tacrolimus: A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS. Qin F; Wang H; Li M; Zhuo S; Liu W Expert Opin Drug Saf; 2023; 22(12):1321-1327. PubMed ID: 37477905 [TBL] [Abstract][Full Text] [Related]
2. Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients. Giguère P; Deschenes MJ; Van Loon M; Hoar S; Fairhead T; Pazhekattu R; Knoll G; Karpinski J; Parikh N; McDougall J; McGuinty M; Hiremath S Clin J Am Soc Nephrol; 2023 Jul; 18(7):913-919. PubMed ID: 37099447 [TBL] [Abstract][Full Text] [Related]
3. "Saving lives with nirmatrelvir/ritonavir one transplant patient at a time". Belden KA; Yeager S; Schulte J; Cantarin MPM; Moss S; Royer T; Coppock D Transpl Infect Dis; 2023 Apr; 25(2):e14037. PubMed ID: 36847419 [TBL] [Abstract][Full Text] [Related]
4. Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant. Young C; Papiro T; Greenberg JH Pediatr Nephrol; 2023 Apr; 38(4):1387-1388. PubMed ID: 35982345 [TBL] [Abstract][Full Text] [Related]
5. Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series. Guzmán Cordero C; Saez-Torres de Vicente M Eur J Hosp Pharm; 2024 Feb; 31(2):175-177. PubMed ID: 36535689 [TBL] [Abstract][Full Text] [Related]
6. A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19. Tomida T; Itohara K; Yamamoto K; Kimura T; Fujita K; Uda A; Kitahiro Y; Yokoyama N; Hyodo Y; Omura T; Yano I Drug Metab Pharmacokinet; 2023 Dec; 53():100529. PubMed ID: 37924724 [TBL] [Abstract][Full Text] [Related]
7. Nirmatrelvir/ritonavir treatment of patients with COVID-19 taking tacrolimus: case series describing the results of drug-drug interactions. Shen D; Gong Y; Qian Y; Zhu J; Gao J J Int Med Res; 2024 May; 52(5):3000605241247705. PubMed ID: 38698526 [TBL] [Abstract][Full Text] [Related]
8. Adverse Events Associated with Nirmatrelvir/Ritonavir: A Pharmacovigilance Analysis Based on FAERS. Li M; Zhang QS; Liu XL; Wang HL; Liu W Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558906 [TBL] [Abstract][Full Text] [Related]
9. Tacrolimus toxicity due to enzyme inhibition from ritonavir. Snee I; Drobina J; Mazer-Amirshahi M Am J Emerg Med; 2023 Jul; 69():218.e5-218.e7. PubMed ID: 37173153 [TBL] [Abstract][Full Text] [Related]
10. Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients. Schneider J; Wobser R; Kühn W; Wagner D; Tanriver Y; Walz G BMC Nephrol; 2023 Apr; 24(1):99. PubMed ID: 37061677 [TBL] [Abstract][Full Text] [Related]
11. Nirmatrelvir/ritonavir-induced elevation of blood tacrolimus levels in a patient in the maintenance phase post liver transplantation. Shiohira H; Arakaki S; Uehara W; Uehara H; Yamamoto K; Nakamura K J Infect Chemother; 2024 Jan; 30(1):77-80. PubMed ID: 37689137 [TBL] [Abstract][Full Text] [Related]
12. A case report of drug interaction between co-packaged nirmatrelvir-ritonavir and tacrolimus causing hyponatremia in a lung transplant recipient. Lo CM; Chen WH; Tsai MY; Lu HI; Hsiao YH; Chuang KH; Chen Y; Wu HF; Huang KT; Wang YH J Cardiothorac Surg; 2024 Mar; 19(1):132. PubMed ID: 38491538 [TBL] [Abstract][Full Text] [Related]
13. Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report. Prikis M; Cameron A Transplant Proc; 2022; 54(6):1557-1560. PubMed ID: 35599203 [TBL] [Abstract][Full Text] [Related]
14. Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin. Sindelar M; McCabe D; Carroll E J Med Toxicol; 2023 Jan; 19(1):45-48. PubMed ID: 36536192 [TBL] [Abstract][Full Text] [Related]
15. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion. Marsh J; Logan AT; Bilgili EP; Bowman LJ; Webb AR Am J Health Syst Pharm; 2024 Jun; 81(13):e345-e352. PubMed ID: 38347740 [TBL] [Abstract][Full Text] [Related]
16. Elevated Tacrolimus Blood Concentration Due to the Interaction with Nirmatrelvir/Ritonavir During COVID-19 Treatment: A Case Report. Cordero CG; de Vicente MS Transplant Proc; 2023 Oct; 55(8):1826-1828. PubMed ID: 37037726 [TBL] [Abstract][Full Text] [Related]
17. Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure. Kamo M; Sogawa R; Shimanoe C In Vivo; 2024; 38(4):1841-1846. PubMed ID: 38936945 [TBL] [Abstract][Full Text] [Related]
18. Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database. Gérard AO; Laurain A; Fresse A; Parassol N; Muzzone M; Rocher F; Esnault VLM; Drici MD Clin Pharmacol Ther; 2021 Apr; 109(4):1021-1024. PubMed ID: 33340409 [TBL] [Abstract][Full Text] [Related]
19. Adverse Events of SARS-CoV-2 Therapy: A Pharmacovigilance Study of the FAERS Database. Pannu V; Udongwo N; Imburgio S; Johal A; Mararenko A; Pozdniakova H; Amin T; Patel S; Hossain M; Mushtaq A; Liu E; Fune JM; Heaton J Ann Pharmacother; 2024 Feb; 58(2):105-109. PubMed ID: 37144730 [TBL] [Abstract][Full Text] [Related]
20. Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series. Dewey KW; Yen B; Lazo J; Seijo L; Jariwala R; Shah RJ; Quan D; Carpenter B; Paul Singer J; Breen K; Hays S; Florez R Transplantation; 2023 May; 107(5):1200-1205. PubMed ID: 36525555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]